Insulet posts clinical data on fully closed-loop insulin delivery system

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
Drug Delivery Business

Insulet shares study outcomes supporting fully closed-loop insulin pump for type 2 diabetes

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Stitch Fix, Inc. (NASDAQ: SFIX) Q2 2026 earnings call transcript

Stitch Fix, Inc. (NASDAQ:SFIX) Q2 2026 Earnings Call Transcript March 11, 2026 Stitch Fix, Inc. beats earnings expectations. Reported EPS is $-0.01975, expectations were $-0.05333. Operator: Hello, ...